Kanada - angleščina - Health Canada

rhodiapharm inc - prazosin (prazosin hydrochloride) - tablet - 5mg - prazosin (prazosin hydrochloride) 5mg - alpha-adrenergic blocking agents

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - prazosin hydrochloride 1.1mg equivalent to 1 mg prazosin;  ; prazosin hydrochloride 1.1mg equivalent to 1 mg prazosin - tablet - 1 mg - active: prazosin hydrochloride 1.1mg equivalent to 1 mg prazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose polysorbate 80 quinoline yellow sunset yellow fcf active: prazosin hydrochloride 1.1mg equivalent to 1 mg prazosin excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose polysorbate 80 - hypertension: prazosin is effective in the management of primary hypertension, and also secondary hypertension from various causes. prazosin may be used as the sole agent, but it is generally more effective if used in combination with a diuretic. prazosin can be used successfully with other antihypertensive agents. prazosin may be used safely by hypertensive patients with impaired renal function. congestive cardiac failure: prazosin may be added to the therapeutic regime of patients who have become refactory to conventional therapy with cardiac glycosides and diuretics. raynaud's phenomenon and raynaud's disease benign prostatic hyperplasia: an adjunct in the symptomatic treatment of urinary obstruction caused by bph in patients waiting for prostatic surgery

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - prazosin hydrochloride, quantity: 5.5 mg (equivalent: prazosin, qty 5 mg) - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; polysorbate 80; croscarmellose sodium; magnesium stearate - in patients with hypertension: prazosin is indicated in the treatment of hypertension of varied aetiology and all grades of severity. it can be used as the initial and sole agent or it may be employed in a general treatment programme in conjunction with other antihypertensive agents. renal blood flow and glomerular filtration rate are not impaired by long term oral administration. prazosin can be used with safety in hypertensive patients with impaired renal function. in patients with congestive heart failure: prazosin is indicated in the treatment of severe refractory congestive heart failure. prazosin may be added to the therapeutic regimen in those patients who have become refractory to conventional therapy with cardiac glycosides and diuretics. in patients with raynaud's phenomenon and raynaud's disease: prazosin is indicated in the treatment of raynaud's phenomenon and raynaud's disease. benign prostatic hyperplasia: prazosin is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia in patients awaiting prostatic surgery.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - prazosin hydrochloride, quantity: 2.2 mg (equivalent: prazosin, qty 2 mg) - tablet, uncoated - excipient ingredients: croscarmellose sodium; lactose monohydrate; polysorbate 80; magnesium stearate; microcrystalline cellulose - in patients with hypertension: prazosin is indicated in the treatment of hypertension of varied aetiology and all grades of severity. it can be used as the initial and sole agent or it may be employed in a general treatment programme in conjunction with other antihypertensive agents. renal blood flow and glomerular filtration rate are not impaired by long term oral administration. prazosin can be used with safety in hypertensive patients with impaired renal function. in patients with congestive heart failure: prazosin is indicated in the treatment of severe refractory congestive heart failure. prazosin may be added to the therapeutic regimen in those patients who have become refractory to conventional therapy with cardiac glycosides and diuretics. in patients with raynaud's phenomenon and raynaud's disease: prazosin is indicated in the treatment of raynaud's phenomenon and raynaud's disease. benign prostatic hyperplasia: prazosin is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia in patients awaiting prostatic surgery.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - prazosin hydrochloride, quantity: 1.1 mg (equivalent: prazosin, qty 1 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; polysorbate 80 - in patients with hypertension: prazosin is indicated in the treatment of hypertension of varied aetiology and all grades of severity. it can be used as the initial and sole agent or it may be employed in a general treatment programme in conjunction with other antihypertensive agents. renal blood flow and glomerular filtration rate are not impaired by long term oral administration. prazosin can be used with safety in hypertensive patients with impaired renal function. in patients with congestive heart failure: prazosin is indicated in the treatment of severe refractory congestive heart failure. prazosin may be added to the therapeutic regimen in those patients who have become refractory to conventional therapy with cardiac glycosides and diuretics. in patients with raynaud's phenomenon and raynaud's disease: prazosin is indicated in the treatment of raynaud's phenomenon and raynaud's disease. benign prostatic hyperplasia: prazosin is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia in patients awaiting prostatic surgery.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

remedyrepack inc. - prazosin hydrochloride (unii: x0z7454b90) (prazosin - unii:xm03yj541d) - prazosin 2 mg

Združene države Amerike - angleščina - NLM (National Library of Medicine)

a-s medication solutions - prazosin hydrochloride (unii: x0z7454b90) (prazosin - unii:xm03yj541d) - prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes and

Združene države Amerike - angleščina - NLM (National Library of Medicine)

remedyrepack inc. - prazosin hydrochloride (unii: x0z7454b90) (prazosin - unii:xm03yj541d) - prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes and

Združene države Amerike - angleščina - NLM (National Library of Medicine)

bryant ranch prepack - prazosin hydrochloride (unii: x0z7454b90) (prazosin - unii:xm03yj541d) - prazosin hydrochloride capsules, usp is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes

Združene države Amerike - angleščina - NLM (National Library of Medicine)

bryant ranch prepack - prazosin hydrochloride (unii: x0z7454b90) (prazosin - unii:xm03yj541d) - prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes and